MEDCARE, Inc. announced that it has received funding from cocokara fine Inc., SMBC Venture Capital Co., Ltd., Euglena Co., Ltd., Mitsui & Co., Ltd., Mitsubishi UFJ Capital Co. Ltd.
May 14, 2018
Share
On May 15, 2018 MEDCARE, Inc. closed the transaction. The transaction also involved participation from new investors SMBC Venture Capital Co., Ltd., Euglena Co., Ltd. (TSE:2931), Mitsui & Co., Ltd. (TSE:8031), and Mitsubishi UFJ Capital Co. Ltd.
euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.
MEDCARE, Inc. announced that it has received funding from cocokara fine Inc., SMBC Venture Capital Co., Ltd., Euglena Co., Ltd., Mitsui & Co., Ltd., Mitsubishi UFJ Capital Co. Ltd.
EUGLENA CO., LTD. 
